Cargando…
Agriophyllum Oligosaccharides Ameliorate Diabetic Insulin Resistance Through INS-R/IRS/Glut4-Mediated Insulin Pathway in db/db Mice and MIN6 Cells
We have previously reported that Agriophyllum oligosaccharides (AOS) significantly enhance glycemic control by increasing the activation of insulin receptor (INS-R), insulin receptor substrate-2 (IRS-2), phosphatidylinositol 3 kinase (PI3K), protein kinase B (AKT), peroxisome proliferator-activated...
Autores principales: | , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8419282/ https://www.ncbi.nlm.nih.gov/pubmed/34497509 http://dx.doi.org/10.3389/fphar.2021.656220 |
_version_ | 1783748715670929408 |
---|---|
author | Bao, Shuyin Wang, Xiuzhi Cho, Sung Bo Wu, Yan-Ling Wei, Chengxi Han, Shuying Bao, Liming Wu, Qiong Ao, Wuliji Nan, Ji-Xing |
author_facet | Bao, Shuyin Wang, Xiuzhi Cho, Sung Bo Wu, Yan-Ling Wei, Chengxi Han, Shuying Bao, Liming Wu, Qiong Ao, Wuliji Nan, Ji-Xing |
author_sort | Bao, Shuyin |
collection | PubMed |
description | We have previously reported that Agriophyllum oligosaccharides (AOS) significantly enhance glycemic control by increasing the activation of insulin receptor (INS-R), insulin receptor substrate-2 (IRS-2), phosphatidylinositol 3 kinase (PI3K), protein kinase B (AKT), peroxisome proliferator-activated receptor (PPAR)-γ, and glucose transporter 4 (Glut4) proteins in hepatic tissues. However, the effect of glucose control by AOS on the regulation of pancreatic tissues in db/db mice and MIN6 cells remains to be determined. An oral dose of AOS (380 or 750 mg/kg) was administered to type-2 diabetic db/db mice for 8 weeks to determine whether AOS regulates glucose by the INS-R/IRS/Glut4-mediated insulin pathway. Meanwhile, the effects of AOS on glucose uptake and its related signaling pathway in MIN6 cells were also investigated. The results showed that the random blood glucose (RBG) level in the AOS-treated group was lower than that in the control group. AOS reduced the levels of glycated hemoglobin (HbA1c) and free fatty acid (FFA) and significantly improved the pathological changes in the pancreatic tissues in db/db mice. Moreover, immunohistochemical analysis revealed that the expression of INS-R, IRS-1, IRS-2, and Glut4 was increased in the AOS-treated group than in the model group. Further, in vitro experiments using MIN6 cells showed that AOS regulated INS-R, IRS-1, IRS-2, and Glut4 protein and mRNA levels and attenuated insulin resistance and cell apoptosis. The results of both in vitro and in vivo experiments were comparable. Ultra-performance liquid chromatography coupled with time-of-flight mass spectrometric analysis of AOS with precolumn derivatization with 3-amino-9-ethylcarbazole (AEC) tentatively identified five types of sugars: glucose, lactose, rutinose, glucuronic acid, and maltotriose. Our present study clearly showed that AOS is efficacious in preventing hyperglycemia, possibly by increasing insulin sensitivity and improving IR by regulating the INS-R/IRS/Glut4 insulin signal pathway. Therefore, AOS may be considered as a potential drug for diabetes treatment. |
format | Online Article Text |
id | pubmed-8419282 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | Frontiers Media S.A. |
record_format | MEDLINE/PubMed |
spelling | pubmed-84192822021-09-07 Agriophyllum Oligosaccharides Ameliorate Diabetic Insulin Resistance Through INS-R/IRS/Glut4-Mediated Insulin Pathway in db/db Mice and MIN6 Cells Bao, Shuyin Wang, Xiuzhi Cho, Sung Bo Wu, Yan-Ling Wei, Chengxi Han, Shuying Bao, Liming Wu, Qiong Ao, Wuliji Nan, Ji-Xing Front Pharmacol Pharmacology We have previously reported that Agriophyllum oligosaccharides (AOS) significantly enhance glycemic control by increasing the activation of insulin receptor (INS-R), insulin receptor substrate-2 (IRS-2), phosphatidylinositol 3 kinase (PI3K), protein kinase B (AKT), peroxisome proliferator-activated receptor (PPAR)-γ, and glucose transporter 4 (Glut4) proteins in hepatic tissues. However, the effect of glucose control by AOS on the regulation of pancreatic tissues in db/db mice and MIN6 cells remains to be determined. An oral dose of AOS (380 or 750 mg/kg) was administered to type-2 diabetic db/db mice for 8 weeks to determine whether AOS regulates glucose by the INS-R/IRS/Glut4-mediated insulin pathway. Meanwhile, the effects of AOS on glucose uptake and its related signaling pathway in MIN6 cells were also investigated. The results showed that the random blood glucose (RBG) level in the AOS-treated group was lower than that in the control group. AOS reduced the levels of glycated hemoglobin (HbA1c) and free fatty acid (FFA) and significantly improved the pathological changes in the pancreatic tissues in db/db mice. Moreover, immunohistochemical analysis revealed that the expression of INS-R, IRS-1, IRS-2, and Glut4 was increased in the AOS-treated group than in the model group. Further, in vitro experiments using MIN6 cells showed that AOS regulated INS-R, IRS-1, IRS-2, and Glut4 protein and mRNA levels and attenuated insulin resistance and cell apoptosis. The results of both in vitro and in vivo experiments were comparable. Ultra-performance liquid chromatography coupled with time-of-flight mass spectrometric analysis of AOS with precolumn derivatization with 3-amino-9-ethylcarbazole (AEC) tentatively identified five types of sugars: glucose, lactose, rutinose, glucuronic acid, and maltotriose. Our present study clearly showed that AOS is efficacious in preventing hyperglycemia, possibly by increasing insulin sensitivity and improving IR by regulating the INS-R/IRS/Glut4 insulin signal pathway. Therefore, AOS may be considered as a potential drug for diabetes treatment. Frontiers Media S.A. 2021-08-23 /pmc/articles/PMC8419282/ /pubmed/34497509 http://dx.doi.org/10.3389/fphar.2021.656220 Text en Copyright © 2021 Bao, Wang, Cho, Wu, Wei, Han, Bao, Wu, Ao and Nan. https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms. |
spellingShingle | Pharmacology Bao, Shuyin Wang, Xiuzhi Cho, Sung Bo Wu, Yan-Ling Wei, Chengxi Han, Shuying Bao, Liming Wu, Qiong Ao, Wuliji Nan, Ji-Xing Agriophyllum Oligosaccharides Ameliorate Diabetic Insulin Resistance Through INS-R/IRS/Glut4-Mediated Insulin Pathway in db/db Mice and MIN6 Cells |
title | Agriophyllum Oligosaccharides Ameliorate Diabetic Insulin Resistance Through INS-R/IRS/Glut4-Mediated Insulin Pathway in db/db Mice and MIN6 Cells |
title_full | Agriophyllum Oligosaccharides Ameliorate Diabetic Insulin Resistance Through INS-R/IRS/Glut4-Mediated Insulin Pathway in db/db Mice and MIN6 Cells |
title_fullStr | Agriophyllum Oligosaccharides Ameliorate Diabetic Insulin Resistance Through INS-R/IRS/Glut4-Mediated Insulin Pathway in db/db Mice and MIN6 Cells |
title_full_unstemmed | Agriophyllum Oligosaccharides Ameliorate Diabetic Insulin Resistance Through INS-R/IRS/Glut4-Mediated Insulin Pathway in db/db Mice and MIN6 Cells |
title_short | Agriophyllum Oligosaccharides Ameliorate Diabetic Insulin Resistance Through INS-R/IRS/Glut4-Mediated Insulin Pathway in db/db Mice and MIN6 Cells |
title_sort | agriophyllum oligosaccharides ameliorate diabetic insulin resistance through ins-r/irs/glut4-mediated insulin pathway in db/db mice and min6 cells |
topic | Pharmacology |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8419282/ https://www.ncbi.nlm.nih.gov/pubmed/34497509 http://dx.doi.org/10.3389/fphar.2021.656220 |
work_keys_str_mv | AT baoshuyin agriophyllumoligosaccharidesamelioratediabeticinsulinresistancethroughinsrirsglut4mediatedinsulinpathwayindbdbmiceandmin6cells AT wangxiuzhi agriophyllumoligosaccharidesamelioratediabeticinsulinresistancethroughinsrirsglut4mediatedinsulinpathwayindbdbmiceandmin6cells AT chosungbo agriophyllumoligosaccharidesamelioratediabeticinsulinresistancethroughinsrirsglut4mediatedinsulinpathwayindbdbmiceandmin6cells AT wuyanling agriophyllumoligosaccharidesamelioratediabeticinsulinresistancethroughinsrirsglut4mediatedinsulinpathwayindbdbmiceandmin6cells AT weichengxi agriophyllumoligosaccharidesamelioratediabeticinsulinresistancethroughinsrirsglut4mediatedinsulinpathwayindbdbmiceandmin6cells AT hanshuying agriophyllumoligosaccharidesamelioratediabeticinsulinresistancethroughinsrirsglut4mediatedinsulinpathwayindbdbmiceandmin6cells AT baoliming agriophyllumoligosaccharidesamelioratediabeticinsulinresistancethroughinsrirsglut4mediatedinsulinpathwayindbdbmiceandmin6cells AT wuqiong agriophyllumoligosaccharidesamelioratediabeticinsulinresistancethroughinsrirsglut4mediatedinsulinpathwayindbdbmiceandmin6cells AT aowuliji agriophyllumoligosaccharidesamelioratediabeticinsulinresistancethroughinsrirsglut4mediatedinsulinpathwayindbdbmiceandmin6cells AT nanjixing agriophyllumoligosaccharidesamelioratediabeticinsulinresistancethroughinsrirsglut4mediatedinsulinpathwayindbdbmiceandmin6cells |